Published in Infect Immun on October 15, 2007
Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. J Biol Chem (2009) 1.16
Human L-ficolin (ficolin-2) and its clinical significance. J Biomed Biotechnol (2012) 1.12
Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol (2009) 1.00
Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation. J Infect Dis (2014) 0.91
The interaction pattern of murine serum ficolin-A with microorganisms. PLoS One (2012) 0.86
L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci. Infect Immun (2012) 0.85
The lectin pathway of complement and rheumatic heart disease. Front Pediatr (2015) 0.84
Commercially available complement component-depleted sera are unexpectedly codepleted of ficolin-2. Clin Vaccine Immunol (2014) 0.80
Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation. Respir Res (2012) 0.78
Identification of potential serum biomarkers for rheumatoid arthritis by high-resolution quantitative proteomic analysis. Inflammation (2014) 0.75
The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J Biol Chem (1960) 21.21
Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J (1961) 17.21
Diffusion-in-gel methods for immunological analysis. II. Prog Allergy (1962) 6.73
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48
A rapid procedure for the estimation of amino sugars on a micro scale. Anal Biochem (1966) 3.32
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23
Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature (1992) 3.19
Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med (2001) 3.09
The lectin-complement pathway--its role in innate immunity and evolution. Immunol Rev (2004) 2.73
Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun (2000) 2.71
Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen. J Biol Chem (1987) 2.35
Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Mol Microbiol (1993) 2.09
Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest (2005) 2.07
Discovery and characterization of sialic acid O-acetylation in group B Streptococcus. Proc Natl Acad Sci U S A (2004) 1.93
A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J Biol Chem (1996) 1.88
Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus. Can J Biochem (1980) 1.83
Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis (1979) 1.71
L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol (2004) 1.70
L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem (2004) 1.70
The capsule polysaccharide synthesis locus of streptococcus pneumoniae serotype 14: Identification of the glycosyl transferase gene cps14E. J Bacteriol (1996) 1.67
Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun (2005) 1.64
Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J Infect Dis (1998) 1.63
Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect Immun (1992) 1.56
Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus. Biochemistry (1983) 1.54
Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J (2007) 1.53
An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods (2001) 1.50
Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet (2005) 1.50
Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus. J Biol Chem (1983) 1.46
Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide. J Biol Chem (1991) 1.44
Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide. J Biol Chem (1996) 1.41
Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression. Infect Immun (1989) 1.38
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis (2004) 1.36
Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol (2005) 1.35
Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. J Biol Chem (2004) 1.29
The role of ficolins in innate immunity. Immunobiology (2002) 1.29
Restriction endonuclease digest patterns of chromosomal DNA from group B beta-haemolytic streptococci. J Med Microbiol (1991) 1.24
Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol (2005) 1.17
Correlation of phylogenetic lineages of group B Streptococci, identified by analysis of restriction-digestion patterns of genomic DNA, with infB alleles and mobile genetic elements. J Infect Dis (2002) 1.14
Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci. J Immunol (2005) 1.13
Isolation and characterization of type IV group B Streptococcus capsular polysaccharide. Infect Immun (1989) 1.13
Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci). Infect Immun (1993) 1.12
Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol (1994) 1.09
The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes. Immunobiology (2002) 1.08
Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: mannan-binding protein and conglutinin. Biochem J (1993) 1.07
Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J Bacteriol (2005) 1.06
Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis (2001) 1.05
Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy. Carbohydr Res (1995) 1.01
Capsular sialic acid limits C5a production on type III group B streptococci. Infect Immun (1999) 0.97
Multiantennary group-specific polysaccharide of group B Streptococcus. Biochemistry (1988) 0.91
Characterization of the interaction between L-ficolin/p35 and mannan-binding lectin-associated serine proteases-1 and -2. J Immunol (2002) 0.89
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A (2005) 14.59
Multilocus sequence typing system for group B streptococcus. J Clin Microbiol (2003) 6.22
Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med (2012) 3.94
Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth (2010) 3.89
A framework for strategic investments in research to reduce the global burden of preterm birth. Am J Obstet Gynecol (2012) 3.19
The lectin-complement pathway--its role in innate immunity and evolution. Immunol Rev (2004) 2.73
Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions. BMC Pregnancy Childbirth (2010) 2.63
Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet (2013) 2.60
Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect Immun (2005) 2.51
A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology (2006) 1.92
Global report on preterm birth and stillbirth (2 of 7): discovery science. BMC Pregnancy Childbirth (2010) 1.79
Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol (2006) 1.78
Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. Infect Immun (2002) 1.77
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol (2006) 1.72
A eukaryotic type serine/threonine kinase and phosphatase in Streptococcus agalactiae reversibly phosphorylate an inorganic pyrophosphatase and affect growth, cell segregation, and virulence. J Biol Chem (2003) 1.72
Global report on preterm birth and stillbirth (4 of 7): delivery of interventions. BMC Pregnancy Childbirth (2010) 1.71
L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem (2004) 1.70
L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol (2004) 1.70
Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest (2006) 1.69
Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun (2005) 1.64
Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med (2010) 1.62
Curved-end guidewire for central venous cannulation in neonate. Anesth Analg (2003) 1.59
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A (2011) 1.58
Characterization of the accessory Sec system of Staphylococcus aureus. J Bacteriol (2008) 1.56
Stillbirths: the vision for 2020. Lancet (2011) 1.55
Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J (2007) 1.53
Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol (2004) 1.53
Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. J Exp Med (2009) 1.51
Preventing preterm birth and neonatal mortality: exploring the epidemiology, causes, and interventions. Semin Perinatol (2010) 1.51
Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol (2008) 1.50
Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet (2005) 1.50
Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis (2011) 1.49
Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol (2005) 1.49
Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J Clin Microbiol (2003) 1.46
Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study. J Clin Microbiol (2006) 1.41
Evaluation of the Arrow Flex Tip Plus epidural catheter tip position and migration during continuous thoracic analgesia. Can J Anaesth (2003) 1.40
Regulation of cytotoxin expression by converging eukaryotic-type and two-component signalling mechanisms in Streptococcus agalactiae. Mol Microbiol (2006) 1.39
A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest (2003) 1.36
Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae. Infect Immun (2003) 1.33
Phylogenetic relationships among Streptococcus agalactiae isolated from piscine, dolphin, bovine and human sources: a dolphin and piscine lineage associated with a fish epidemic in Kuwait is also associated with human neonatal infections in Japan. J Med Microbiol (2008) 1.32
Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. J Biol Chem (2004) 1.29
The role of ficolins in innate immunity. Immunobiology (2002) 1.29
The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. PLoS Pathog (2012) 1.28
Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology (2005) 1.26
Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections. Emerg Infect Dis (2004) 1.25
Global report on preterm birth and stillbirth (6 of 7): ethical considerations. BMC Pregnancy Childbirth (2010) 1.24
Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet (2013) 1.23
Limited genetic diversity of recent invasive isolates of non-serotype b encapsulated Haemophilus influenzae. J Clin Microbiol (2002) 1.23
Nontypeable Haemophilus influenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression. Infect Immun (2006) 1.22
Priming the immune system for heart disease: a perspective on group A streptococci. J Infect Dis (2010) 1.21
The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway. J Immunol (2011) 1.20
Variants in TNFAIP3, STAT4, and C12orf30 loci associated with multiple autoimmune diseases are also associated with juvenile idiopathic arthritis. Arthritis Rheum (2009) 1.20
Role of ficolin in innate immunity and its molecular basis. Immunobiology (2007) 1.19
Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J Immunol (2002) 1.19
Fatal acute fibrinous and organizing pneumonia in a child with juvenile dermatomyositis. J Pediatr (2005) 1.18
Prevalence and distribution of adhesins in invasive non-type b encapsulated Haemophilus influenzae. Infect Immun (2003) 1.17
Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol (2004) 1.15
Correlation of phylogenetic lineages of group B Streptococci, identified by analysis of restriction-digestion patterns of genomic DNA, with infB alleles and mobile genetic elements. J Infect Dis (2002) 1.14
Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci. J Immunol (2005) 1.13
The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma. Clin Cancer Res (2004) 1.13
Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest (2004) 1.12
Global report on preterm birth and stillbirth (5 of 7): advocacy barriers and opportunities. BMC Pregnancy Childbirth (2010) 1.11
Lectin complement system and pattern recognition. Immunobiology (2006) 1.11
Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway. J Immunol (2006) 1.10
Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology (2010) 1.10
Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer. Pediatr Infect Dis J (2011) 1.10
Long-range mapping of the Streptococcus agalactiae phylogenetic lineage restriction digest pattern type III-3 reveals clustering of virulence genes. Infect Immun (2002) 1.09
Structure of Streptococcus agalactiae serine/threonine phosphatase. The subdomain conformation is coupled to the binding of a third metal ion. FEBS J (2007) 1.09
MtaR, a regulator of methionine transport, is critical for survival of group B streptococcus in vivo. J Bacteriol (2003) 1.09
Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int Immunol (2006) 1.09
Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function. BMC Nephrol (2011) 1.08
Next-generation sequencing reveals genomic features in the Japanese quail. Genomics (2013) 1.07